| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.2 |